KAYLEE KAISER: Open Payments
NPI 1578180907 · RUSSELL, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 17 payments from 11 companies in 2025. Trend: 2023 $776 · 2024 $374 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $50 |
| Insulet Corporation | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| ABBVIE INC. | 2 | $32 |
| Electromed, Inc. | 2 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: EVENITY, Omnipod, LEQVIO, SMARTVEST, ELIQUIS, UBRELVY, QULIPTA, AIRSUPRA.
Industry payments across KS — which companies pay providers there.
